CLOSEOUT LETTER
Tampa Humidor
- Recipient:
- Tampa Humidor
United States
- Issuing Office:
United States
Center for Tobacco Products 10903 New Hampshire Avenue Silver Spring, MD 20993 |
MAR 13, 2017
VIA Electronic Mail
Tampa Humidor
Attn: Michael Howe
sales@tampahumidor.com
theresa@tampahumidor.com
Dear Michael Howe:
The United States Food and Drug Administration's (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your letter received on September 21, 2016, in response to our Warning Letter dated September 2, 2016. Based on our evaluation, it appears that you have taken steps to address the violation contained in the Warning Letter for the website http://www.tampahumidor.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/S/
Bryan Hills
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
VIA Electronic Mail
cc:
Network Solutions, LLC
abuse@web.com
Bayshore Solutions
abuse@bayshoresolutions.com